相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Uremic Toxins and Oral Adsorbents
Shunsuke Goto et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2011)
Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent manner
Tsukasa Nakamura et al.
PHARMACOLOGICAL RESEARCH (2010)
Urinary L-Type Fatty Acid-Binding Protein Can Reflect Renal Tubulointerstitial Injury
Tamami Tanaka et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Erythropoietin and renoprotection
Ferdinand H. Bahlmann et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2009)
The impact of pulse wave velocity in a Japanese population with metabolic syndrome
Akihiro Hirashiki et al.
HYPERTENSION RESEARCH (2009)
Plasma Brain Natriuretic Peptide as an Independent Predictor of In-Hospital Mortality after Acute Ischemic Stroke
Kensaku Shibazaki et al.
INTERNAL MEDICINE (2009)
Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease (CKD)
Seiji Ueda et al.
LIFE SCIENCES (2009)
Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner
Tsukasa Nakamura et al.
PHARMACOLOGICAL RESEARCH (2009)
Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence
S. Dhar et al.
POSTGRADUATE MEDICAL JOURNAL (2009)
Natriuretic Peptides in Chronic Kidney Disease
Rajat Tagore et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency
Tsukasa Nakamura et al.
HYPERTENSION RESEARCH (2008)
Erythropoietin and its non-erythropoietic derivative: Do they ameliorate renal tubulointerstitial injury in ureteral obstruction?
Nattachai Srisawat et al.
INTERNATIONAL JOURNAL OF UROLOGY (2008)
Protective effect of Epo on oxidative renal injury in rats with cyclosporine nephrotoxicity
Belde Kasap et al.
PEDIATRIC NEPHROLOGY (2008)
Multiorgan-protective actions of blockers of the renin-angiotensin system, statins and erythropoietin: common pteiotropic effects in reno-, cardio- and neuroprotection
G. Gluhovschi et al.
ACTA CLINICA BELGICA (2008)
Cellular protection by erythropoietin: New therapeutic implications?
M. Joyeux-Faure
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan
Enyu Imai et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney disease
Tsukasa Nakamura et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2007)
The past, presence and future of ADMA in nephrology
Jan T. Kielstein et al.
NEPHROLOGIE & THERAPEUTIQUE (2007)
Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery - An epidemiological study
Kumiko Furuki et al.
ATHEROSCLEROSIS (2007)
Association between carotid artery intima-media thickness and early-stage CKD in a Chinese population
LuXia Zhang et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease
Kyoko Matsuguma et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Long-term erythropoietin therapy decreases CC-chemokine levels and intima-media thickness in hemodialyzed patients
Krystyna Pawlak et al.
AMERICAN JOURNAL OF NEPHROLOGY (2006)
Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD
E Preston et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dL
JC Ayus et al.
KIDNEY INTERNATIONAL (2005)
Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease
MC Wang et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease
A Kamijo et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2004)
分享论文
